Despite limited growth expectations, Jiangxi Synergy Pharmac...
Despite limited growth expectations, Jiangxi Synergy Pharmaceutical's P/E ratio is similar to the market, indicating potential investor oversight. The company's weak earnings outlook and slower growth could risk a share price decline.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000280ae6fe18c848.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment